321 related articles for article (PubMed ID: 21502764)
1. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
3. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and treatment status of hemifacial spasm in China.
Wang L; Hu X; Dong H; Wang W; Huang Y; Jin L; Luo Y; Zhang W; Lian Y; Liang Z; Shang H; Feng Y; Wu Y; Chen J; Luo W; Wan X
Chin Med J (Engl); 2014; 127(5):845-9. PubMed ID: 24571874
[TBL] [Abstract][Full Text] [Related]
5. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
6. A comparison of facial muscle squeezing versus non-facial muscle squeezing on the efficacy of botulinumtoxin-A injections for the treatment of facial dystonia.
O' Reilly P; Ross J; Norris J; Malhotra R
Orbit; 2012 Dec; 31(6):400-3. PubMed ID: 23061606
[TBL] [Abstract][Full Text] [Related]
7. No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
Lorenzano C; Bagnato S; Gilio F; Fabbrini G; Berardelli A
Neurotox Res; 2006 Apr; 9(2-3):141-4. PubMed ID: 16785111
[TBL] [Abstract][Full Text] [Related]
8. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
Lowe NJ; Lask G; Yamauchi P; Moore D
J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
10. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
11. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
12. Hemifacial spasm and posterior auricular muscle.
Kiziltan M; Sahin R; Uzun N; Kiziltan G
Electromyogr Clin Neurophysiol; 2006 Sep; 46(5):317-20. PubMed ID: 17059105
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hemifacial spasm with botulinum A toxin].
Duzyński W; Sławek J
Neurol Neurochir Pol; 1998; 32 Suppl 1():61-9. PubMed ID: 9608555
[TBL] [Abstract][Full Text] [Related]
15. The effects of botulinum toxin A on ephaptic transmission in idiopathic hemifacial spasm.
Kurt T; Seçil Y; Gürgör N; Tokuçoğlu F; Beckmann Y; Ertekin C
Int J Neurosci; 2009; 119(11):2044-55. PubMed ID: 19863260
[TBL] [Abstract][Full Text] [Related]
16. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
17. Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment.
Herrero-Infante Y; Rodríguez-Sanz A; Máñez-Miró J; Vivancos-Matellano F
Clin Neurol Neurosurg; 2021 Apr; 203():106555. PubMed ID: 33662742
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
Barbosa ER; Takada LT; Gonçalves LR; Costa RM; Silveira-Moriyama L; Chien HF
Arq Neuropsiquiatr; 2010 Aug; 68(4):502-5. PubMed ID: 20730300
[TBL] [Abstract][Full Text] [Related]
19. Headache in hemifacial spasm patients.
Peeraully T; Tan SF; Fook-Chong SM; Prakash KM; Tan EK
Acta Neurol Scand; 2013 May; 127(5):e24-7. PubMed ID: 23311349
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
